18 May 2013
Keywords: fda, oks, sanofi-aventis, ambien, cr, insomnia, leading
Article | 12 September 2005
Leading French drugmaker Sanofi-Aventis says that the US Food and Drug Administration has approved its Ambien CR (zolpidem tartrate) CIV, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 September 2005
17 May 2013
© 2013 thepharmaletter.com